Figure 1: Trial profile.
Per protocol, treatment continues until progression. HMA=hypomethylating agent. HSCT=haemopoietic stem-cell transplantation.
Per protocol, treatment continues until progression. HMA=hypomethylating agent. HSCT=haemopoietic stem-cell transplantation.